Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
Aliment Pharmacol Ther
; 44(2): 157-69, 2016 07.
Article
in En
| MEDLINE
| ID: mdl-27218676
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colitis, Ulcerative
/
Matrix Metalloproteinase 9
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Aliment Pharmacol Ther
Year:
2016
Document type:
Article